VERTEX PHARMACEUTICALS INC. - US92532F1003 (Stock)
London
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
483,83 USD
|
-1,6865% | 22.04.2025 15:30 | - | - | - | - |
| Balance ratios | 2024 | 2023 |
|---|---|---|
| Total assets | 23.090.600 USD | 23.086.300 USD |
| Employees | 6.100 | 5.400 |
| Cash and cash equivalents | 4.572.200 USD | 10.372.300 USD |
| Intangible / inalienable assets | 1.913.900 USD | 1.927.900 USD |
| Economic shareholder's equity | 16.409.600 USD | 17.580.400 USD |
| Subscribed Capital | 2.600 USD | 2.600 USD |
| Liabilities | 6.681.000 USD | 5.505.900 USD |
| Liabilities to financial institutions | - | - |
| GuV Zahlen | 2024 | 2023 |
|---|---|---|
| Sales | 10.984.400 USD | 9.839.000 USD |
| Profit after tax | -535.600 USD | 3.619.600 USD |
| Deprecation (??) | 207.200 USD | 169.500 USD |
| Dividend ordinary shares | - | - |
| Net investment income | 0 USD | 0 USD |
| Dividend preferred shares | - | - |
| Net interests income | 567.500 USD | 570.600 USD |
| Earnings from ordinary operating activities | 248.500 USD | 4.379.800 USD |
| Net income (after minority interests) | -535.600 USD | 3.619.600 USD |
| Net earnings per share | -2.08 USD | 13.89 USD |
| Total payout | 0 USD | 0 USD |
| Administrative expenses | - | - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
